Plans to alter routine childhood immunisation schedule announced

From 1st July 2016, infants will no longer receive vaccination against meningococcal serogroup C (MenC), currently given at three months of age.

The dose of combined Hib/Men C offered at 12 months of age will provide good protection to toddlers and younger children. | iStock
The dose of combined Hib/Men C offered at 12 months of age will provide good protection to toddlers and younger children. | iStock

The change to the routine immunisation schedule is based on a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI) in light of the success of the MenC programme in limiting cases of invasive MenC disease. It is believed that ongoing vaccination of adolescents will sustain the high level of herd protection. 

Further information
View MenC vaccine drug record
Letter from PHE

In addition, the new MenB vaccination programme with Bexsero may provide some degree of protection against invasive MenC disease.

Children will continue to be offered the Hib/MenC vaccine (Menitorix) at 12 months of age and the MenACWY conjugate vaccine (Menveo/Nimenrix) at around 14 years of age. 

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases